{"id":523421,"date":"2021-08-04T16:13:13","date_gmt":"2021-08-04T20:13:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nu-skin-enterprises-reports-42-percent-eps-growth-and-15-percent-revenue-growth-in-the-second-quarter\/"},"modified":"2021-08-04T16:13:13","modified_gmt":"2021-08-04T20:13:13","slug":"nu-skin-enterprises-reports-42-percent-eps-growth-and-15-percent-revenue-growth-in-the-second-quarter","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nu-skin-enterprises-reports-42-percent-eps-growth-and-15-percent-revenue-growth-in-the-second-quarter\/","title":{"rendered":"Nu Skin Enterprises Reports 42 Percent EPS Growth And 15 Percent Revenue Growth In The Second Quarter"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n PROVO, Utah<\/span>, Aug. 4, 2021<\/span> \/PRNewswire\/ — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million<\/span> and earnings per share (EPS) of $1.15<\/span> driven by an increase in operating margin of 260 basis points.<\/p>\n

\n

\n
\n \"Nu
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Executive Summary
<\/b>
\n Q2 2021 vs. Prior-year Quarter<\/b>\n <\/p>\n

\n\n\n\n\n\n
\n

\n
\n Revenue:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $704.1 million; +15%<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0+6% fx impact or $36.9 million<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Earnings Per Share
(EPS):<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $1.15; +42%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Sales Leaders:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 64,228; +15%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Customers:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 1,467,617; (2%)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

“Our growth and success this quarter and over the past year reflect our strategy of delivering world-class beauty and wellness products, being customer obsessed, and digitally enabling our business,” said Ritch Wood<\/span>, chief executive officer. “Our performance was led by continued growth in our beauty device systems and further adoption of social commerce. In addition, we significantly improved profitability during the quarter, which led to strong earnings per share growth. We have a solid foundation in place, and I am fully confident in Ryan and our leadership team to build on the momentum and take Nu Skin to the next level.”<\/p>\n

\n Ryan Napierski<\/span>, president and CEO-elect, added, “We continue to advance our vision of becoming the world’s leading beauty and wellness company, powered by our dynamic affiliate opportunity platform. During the quarter, we strengthened our position as the market leader in beauty device systems as our latest device system, ageLOC Boost, generated momentum with a strong launch in EMEA. Additionally, we are pleased with the rollout of Nutricentials Bioadaptives, which is targeted at a millennial\/Gen Z consumer. In the back half of the year, we will be begin rolling out Beauty Focus Collagen+, which leverages our unique strength in both beauty and wellness, and ageLOC Meta, our next significant Pharmanex product introduction. <\/p>\n

“We are pleased with 15 percent growth in sales leaders, while customers declined slightly due to a significant surge in the prior year. To better support our affiliates with customer acquisition, we will be rolling out additional digital tools over the next several quarters such as personalized social commerce shops in Mainland China. This represents a significant step forward in deploying our digital tools in the world’s largest social commerce market.”<\/p>\n

\n Q2 2021 Year-over-year Operating Results\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/b>\n <\/p>\n

\n\n\n\n\n\n\n\n\n\n
\n

\n
\n Revenue:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $704.1 million compared to $612.4 million<\/span>\n <\/p>\n

\n \u00b7\u00a0 +6% fx impact <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Gross Margin:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 75.6% compared to 74.8%<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0Nu Skin business was 78.3% compared to 77.6%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Selling Expenses:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 39.5% compared to 40.6%<\/span>\n <\/p>\n

\n \u00b7\u00a0 Nu Skin business was 42.4% compared to 43.3%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n G&A Expenses:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 24.0% compared to 24.7%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Operating Margin:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 12.1% compared to 9.5% <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Other Income \/
(Expense):<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n ($4.0) million compared to $1.6 million<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Income Tax Rate:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 27.1% compared to 29.8%<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0Benefited by geographic mix<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n EPS:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $1.15 compared to $0.81<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n Stockholder Value<\/b>\n <\/p>\n

\n\n\n\n
\n

\n
\n Dividend Payments:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $19.0 million<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Stock Repurchases:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $10.0 million<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0$265.4 million remaining in authorization<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n Q3 and Full-year 2021 Outlook<\/b>\n <\/p>\n

\n\n\n\n\n\n
\n

\n
\n Q3 2021 Revenue:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $700 to $730 million; 0 to 4%<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0Approximately +2 to 3% fx impact<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Q3 2021 EPS:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $1.10 to $1.20; +2 to 11%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2021 Revenue:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $2.81 to $2.87 billion;\u00a0+9 to 11%<\/span>\n <\/p>\n

\n \u00b7\u00a0\u00a0Approximately +3 to 4% fx impact<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n 2021 EPS:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n $4.30 to $4.50; +18 to 24%<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n Mark Lawrence<\/span>, chief financial officer, added, “We reported 42 percent EPS growth driven by strong improvements in both gross margin and operating margin as a result of continued expense control and supply chain efficiency. We are raising our EPS guidance for the year as we continue to focus on generating enhanced value for our shareholders.”<\/p>\n

\n About Nu Skin Enterprises, Inc. <\/b>\n <\/p>\n

Founded more than 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia<\/span>, the Americas, Europe<\/span>, Africa<\/span> and the Pacific; and Rhyz, our strategic investment arm that includes a collection of sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol “NUS.” More information is available at nuskinenterprises.com<\/a>.<\/p>\n

\n
\n Important Information Regarding Forward-Looking Statements:<\/i>
\n <\/b>
\n \u00a0This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, shareholder value, vision, product pipeline and product introductions, digital tools, customers and sales leaders, affiliates, strategies and initiatives; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as “believe,” “expect,” “anticipate,” “project,” “outlook,” “guidance,” “plan,” “forecast,” “expand,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words.<\/i>\n <\/p>\n

\n The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:<\/i>\n <\/p>\n